Share this via
US stock markets experienced a slight downturn following President Trump's announcement of new tariffs on EU and Mexico goods, sparking trade tension concerns. Despite this, major indexes remained near record highs as investors anticipated potential negotiations before the August 1 deadline. Meanwhile, investors are shifting focus to earnings season, with key banks set to report quarterly results.
As a part of agreement, Incyte has granted to Sun a limited, non-exclusive license to U.S. Patent and certainother related patents with respect to oral deuruxolitinib for certain agreed-upon non-hematology-oncology indications including alopecia areata, in the U.S.
Get over your FOMO of knowing what's happening. Never miss what matters to you!
